MEP Interest Group on Diabetes – MEPs Mobilising for Diabetes (MMD)

MEPs Mobilising for Diabetes (MMD), the MEP Interest Group on Diabetes, for which IDF Europe provides the secretariat, was established in November 2020. The group aims to represent the interests of people living with diabetes, their relatives and carers, as well as those at risk. Under the auspices of co-chairs MEP Sirpa Pietikäinen and MEP Christel Schaldemose, the MMD group works to elevate diabetes on the EU political agenda, promote understanding of the multi-faceted nature of diabetes and dispel common misperceptions.

Through close collaboration with the Commission, Council, and individual Member States (MS), the MMD group aims at fostering EU action around the following priorities:

  • Improving diabetes management, care, and risk reduction approaches
  • Promoting better, more affordable, and uninterrupted access to the required medicines and technologies
  • Eliminating stigma and discrimination against people living with diabetes

Click here to visit the MMD website.

The new EU Parliament Diabetes Resolution

On the Centenary of the Discovery of Insulin and 10 years after the first European Parliament Motion for Resolution on diabetes, on November 23, 2022, the European Parliament adopted a motion for resolution on Prevention, management and better care of diabetes in the EU on the Occasion of World Diabetes Day. IDF Europe applauds this important step forward towards reversing the rising number of people living with diabetes (PwD), improving the management of diabetes and its complications, and addressing the inequalities and disparities in access to care and treatment in Europe.

If put into action, the resolution has the potential to contribute to better health outcomes for millions of EU citizens living with diabetes, as well as with non-communicable diseases (NCDs) and other conditions. IDF Europe thanks President Roberta Metsola and MEPs Mobilising for Diabetes (MMD) for their salient efforts to gather political support, increase awareness of this life-altering disease and their call for urgency to act.

Read the full press release here.

The resolution has the support of the united diabetes community. We want to thank our partners: European Association for the Study of Diabetes (EASD), European Diabetes Forum (EUDF), European Foundation for the Study of Diabetes (EFSD), Foundation of European Nurses in Diabetes (FEND), International Society for Pediatric and Adolescent Diabetes (ISPAD), Juvenile Diabetes Research Foundation (JDRF), Primary Care Diabetes Europe (PCDE), Société Francophone du Diabète (SFD).

We thank our partners, Air Liquide, Boehringer Ingelheim and Lilly Diabetes for their support to our call for a new European Parliament Diabetes Resolution.

Read more about the rationale for a new Diabetes Resolution here


‘Blueprint for Action on Diabetes in the European Union by 2030

The ‘Blueprint for Action on Diabetes in the European Union by 2030’ was launched in February 2021 on the occasion of the official launch of the MMD group.

Written from the perspective of people living with diabetes, the recommendations in this Blueprint cover the whole spectrum of actions to be implemented to improve their lives in Europe. These recommendations are articulated around three key priorities – reducing the risk of developing Type 2 diabetes and diabetes-related complications, integrating care and enabling access. These pillars are supported by three key enablers – engagement of people living with diabetes, digitalisation and data, and research for actionable insights.

Download the Blueprint here


MMD provides a political platform to support the diabetes community and to elevate their united voice at European level.

For more information, check out the MMD website and Twitter account, or email [email protected]

IDF Europe provides the Secretariat for MMD.

MMD receives unrestricted support from EUDF and EFPIA.